Fig. 4

The plasma concentrations of MVs from patient groups DLP (n = 14), T₂D (n = 17), T₂D-DLP (n = 17) and group C (n = 15) of healthy subjects, originating from different cell types: MVs derived from endothelial cells, EMVs: AnnexinV⁺/CD144⁺ (A), platelets, PMVs: AnnexinV⁺/CD41⁺ (B), leucocytes, LeMVs: AnnexinV⁺/CD18⁺ (C), monocytes, MMVs: AnnexinV⁺/CD14⁺ (D), and erythrocytes, ErMVs: AnnexinV⁺/CD235a⁺ (E). Data are expressed as means ± SD. ^&p < 0.05, ^&&p < 0.01, ^&&&p < 0.001, (vs C), ^*p < 0.05, ^**p < 0.01, ^***p < 0.001 (vs DLP), ^#p < 0.05, ^##p < 0.01, ^###p < 0.001 (vs T₂D) (One-Way ANOVA with Bonferroni’s Multiple Comparison Test)